顆粒體蛋白(GRN)多克隆抗體
Polyclonal Antibody to Granulin (GRN)
GEP; GP88; PCDGF; PEPI; PGRN; Proepithelin; Acrogranin; Glycoprotein of 88 Kda; Paragranulin
- 編號UPAC513Hu03
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPC513Hu03-顆粒體蛋白(GRN)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度0.5mg/ml
- 且適物種-
- 應用WB; IHC
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 315 ¥ 735 ¥ 1050 ¥ 2625 ¥ 10500
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
DAB staining on IHC-P; Samples: Human Kidney Tissue; Primary Ab: 20μg/ml Rabbit Anti-Human GRN Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
DAB staining on IHC-P;
Samples: Human Liver Tissue;
Primary Ab: 20μg/ml Rabbit Anti-Human GRN Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19) -
DAB staining on IHC-P;
Sample: Human Liver Tissue
Primary Ab: 20μg/ml Rabbit Anti-Human GRN Antibody
Control: Used PBS instead of primary antibody
Second Ab: 2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19) -
DAB staining on IHC-P;
Sample: Human Kidney Tissue
Primary Ab: 20μg/ml Rabbit Anti-Human GRN Antibody
Control: Used PBS instead of primary antibody
Second Ab: 2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
Figure. Western Blot; Sample: Recombinant GRN, Human.
-
Western Blot; Sample: Human A431 cell lysate;
Primary Ab: 1μg/ml Rabbit Anti-Human GRN Antibody
Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19) -
Knockout Varification:
Lane 1: Wild-type A431 cell lysate;
Lane 2: GRN knockout A431 cell lysate;
Predicted MW: 44,47,64kd
Observed MW: 64kd
Primary Ab: 1μg/ml Rabbit Anti-Human GRN Antibody
Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19) -
Western Blot; Sample: Human U937 cell lysate;
Primary Ab: 1μg/ml Rabbit Anti-Human GRN Antibody
Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對GRN的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別GRN。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| URPC513Hu01 | 顆粒體蛋白(GRN)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPC513Hu02 | 顆粒體蛋白(GRN)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPC513Hu04 | 顆粒體蛋白(GRN)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPC513Hu03 | 顆粒體蛋白(GRN)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAC513Hu02 | 顆粒體蛋白(GRN)多克隆抗體 | IHC |
| UPAC513Hu03 | 顆粒體蛋白(GRN)多克隆抗體 | WB; IHC |
| UPAC513Hu01 | 顆粒體蛋白(GRN)多克隆抗體 | WB; IHC; ICC/IF |
| UPAC513Hu04 | 顆粒體蛋白(GRN)多克隆抗體 | WB; IHC; ICC; IP. |
| ULAC513Hu71 | 顆粒體蛋白(GRN)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| ULAC513Hu81 | 顆粒體蛋白(GRN)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| UMAC513Hu22 | 顆粒體蛋白(GRN)單克隆抗體 | WB; IHC; ICC; IP. |
| USEC513Hu | 顆粒體蛋白(GRN)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| USCC513Hu | 顆粒體蛋白(GRN)檢測試劑盒(化學發光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| ULMC513Hu | 顆粒體蛋白(GRN)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
| UKSC513Hu01 | 顆粒體蛋白(GRN)檢測試劑盒DIY材料(酶聯免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| [] | |
| Endokrynologia Polska | Serum progranulin levels are elevated in infertile women with obesity [Pubmed: 30229554] |
| Endokrynologia?Polska | Effects of serum granulin levels on anthropometric measures and glucose metabolism in infertile women with different ovarian reserve status [Pubmed: 30845343] |
| Sci Rep | AZP2006, a new promising treatment for Alzheimer's and related diseases [34413330] |
留言咨詢
